Everest Medicines grants 1,398,527 share awards under 2026 share scheme

PUBT · 23h ago
Everest Medicines grants 1,398,527 share awards under 2026 share scheme
  • Everest Medicines granted 473,178 share options, exercise price HK$28.05; market price HK$24.72; 7-year exercise term.
  • Options vest 25% per year over four years; no performance targets.
  • Granted up to 1.4 million share awards at nil purchase price; market price HK$24.72.
  • Most awards vest 25% per year over four years; 793,807 also require annual performance appraisal.
  • 30,000 awards vest if the share price reaches HK$100 by Dec. 31, 2027; split 50% on trigger, 50% one year later.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248838), on July 17, 2026, and is solely responsible for the information contained therein.